Validation of hyperbaric oxygen treatment software for use with monoplace chambers.

Rubicon Research Repository/Manakin Repository

Validation of hyperbaric oxygen treatment software for use with monoplace chambers.

Show simple item record


dc.contributor.author Sechrist, JR en_US
dc.contributor.author Warriner, RA 3rd en_US
dc.contributor.author Weninger, AE en_US
dc.contributor.author Ong, R en_US
dc.date.accessioned 2013-10-25T04:30:12Z
dc.date.available 2013-10-25T04:30:12Z
dc.date.issued 2008 en_US
dc.identifier.citation Undersea Hyperb Med. 2008 May-Jun;35(3):219-25. en_US
dc.identifier.isbn 1066-2936 en_US
dc.identifier.other 18619118 en_US
dc.identifier.uri http://archive.rubicon-foundation.org/10307
dc.description Undersea and Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc. en_US
dc.description.abstract Hyperbaric oxygen (HBO2) therapy is increasingly used in the treatment of a wide variety of medical conditions. However, for monoplace chambers, there is some uncertainty when sufficiently high oxygen concentrations are attained, because most chambers are not instrumented to measure oxygen. To remedy this, Microsoft Excel-based software, HBO O2 Smart Guide, was developed to simulate the atmosphere of monoplace chambers during treatment. Based upon chamber dimensions, patient weight, oxygen purge rates, desired pressurization, and HBO2 time, the program calculates oxygen concentration, consumption and exposure for each treatment. Software testing was conducted using four different chambers instrumented with an oxygen analyzer. Two purge rate profiles were used: constant, and biphasic (a high initial purge rate was changed to a lower plateau rate when pressurization was reached). Comparison of measured and calculated times to reach 95 percent oxygen concentration within the chambers demonstrated the software was accurate within 1 percent. The HBO O2 Smart Guide enables optimum purge profiles to be simulated with resultant potential improvements in HBO2 treatment efficacy, calculation of effective oxygen exposures (actual time during prescribed treatment during which patient breathes > or = 95 percent oxygen) to enable more accurate comparison of treatment profiles and outcomes, and cost savings in oxygen usage. This software will enable clinicians to provide more consistent HBO2 treatments. en_US
dc.language.iso en en_US
dc.publisher Undersea and Hyperbaric Medical Society, Inc. en_US
dc.subject monoplace en_US
dc.subject environmental controls en_US
dc.subject control systems en_US
dc.subject hyperbaric chamber en_US
dc.subject methods en_US
dc.subject validation en_US
dc.subject equipment en_US
dc.subject.mesh Hyperbaric Oxygenation/instrumentation/*methods en_US
dc.subject.mesh Oxygen/*analysis en_US
dc.subject.mesh Oxygen Consumption en_US
dc.subject.mesh *Software en_US
dc.subject.mesh *Software Validation en_US
dc.title Validation of hyperbaric oxygen treatment software for use with monoplace chambers. en_US
dc.type Article en_US

Files in this item

Files Size Format View
18619118.pdf 1.042Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

Browse

My Account